• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转基因猪生产的重组人凝血因子IX(rhFIX)在大鼠体内的生物分布及药代动力学

Biodistribution and pharmacokinetics of transgenic pig-produced recombinant human factor IX (rhFIX) in rats.

作者信息

Chang Chih-Hsien, Chou Ta-Kai, Yang Chi-Yu, Chang Tsui-Jung, Wu Yu-Hsien, Lee Te-Wei

机构信息

Division of Isotope Application, Institute of Nuclear Energy Research, Taoyuan, ROC.

出版信息

In Vivo. 2008 Nov-Dec;22(6):693-7.

PMID:19180993
Abstract

BACKGROUND

Recombinant human factor IX (rhFIX) is a 56 kDa glycoprotein with full biological activity providing a guarantee of freedom from blood-borne viral contamination in the therapy of hemophilia B, but no data are available on the distribution of transgenic pig-produced rhFIX post injection (p.i.). Therefore, an 131I-radiolabeled rhFIX was developed to evaluate the distribution of rhFIX in rats.

MATERIALS AND METHODS

rhFIX was labeled with the lodogen method. 131I-rhFIX (25 microCi/25 microg/200 microl/rat) was intravenously injected through the tail vein in normal Sprague-Dawley (SD) rats and the biodistribution was examined from 5 min to 72 h p.i.. The pharmacokinetics were also evaluated from 5 min to 96 h p.i.

RESULTS

The radiolabeled efficiency and radiochemical purity of 131I-rhFIX was over 96% and 98%, respectively. The biodistribution study showed that the rhFIX chiefly accumulated in the liver. The distribution and elimination half-life (t(1/2alpha) and t(1/2beta)) of 131I-rhFIX were 0.82 and 9.34 h, respectively. The maximum concentration in the plasma (Cmax) and the area under the concentration versus time curve (AUC(INF)) of 131I-rhFIX in rats were 3.09% injected dose (ID)/g and 15.3 h x % ID/g.

CONCLUSION

The transgenic pig-produced rhFIX is mostly retained in the liver and the preclinical biodistribution and pharmacokinetic studies of 131I radiolabeled rhFIX are helpful for researching its biological effect in vivo.

摘要

背景

重组人凝血因子IX(rhFIX)是一种具有完全生物活性的56 kDa糖蛋白,在治疗B型血友病时可确保无血源病毒污染,但尚无关于转基因猪生产的rhFIX注射后分布的数据。因此,开发了一种131I放射性标记的rhFIX来评估其在大鼠体内的分布。

材料与方法

采用氯胺T法对rhFIX进行标记。将131I-rhFIX(25微居里/25微克/200微升/只大鼠)经尾静脉注射到正常的Sprague-Dawley(SD)大鼠体内,在注射后5分钟至72小时检测其生物分布。同时在注射后5分钟至96小时评估其药代动力学。

结果

131I-rhFIX的放射性标记效率和放射化学纯度分别超过96%和98%。生物分布研究表明,rhFIX主要蓄积在肝脏。131I-rhFIX的分布半衰期(t(1/2α))和消除半衰期(t(1/2β))分别为0.82小时和9.34小时。大鼠血浆中131I-rhFIX的最大浓度(Cmax)和浓度-时间曲线下面积(AUC(INF))分别为3.09%注射剂量(ID)/克和15.3小时×%ID/克。

结论

转基因猪生产的rhFIX大多保留在肝脏中,131I放射性标记的rhFIX的临床前生物分布和药代动力学研究有助于研究其体内生物学效应。

相似文献

1
Biodistribution and pharmacokinetics of transgenic pig-produced recombinant human factor IX (rhFIX) in rats.转基因猪生产的重组人凝血因子IX(rhFIX)在大鼠体内的生物分布及药代动力学
In Vivo. 2008 Nov-Dec;22(6):693-7.
2
Evaluation of recombinant human factor IX: pharmacokinetic studies in the rat and the dog.重组人凝血因子IX的评估:大鼠和犬的药代动力学研究
Thromb Haemost. 1995 Jan;73(1):101-5.
3
Longitudinal microSPECt/CT imaging and pharmacokinetics of synthetic luteinizing hormone-releasing hormone (LHRH) vaccine in rats.合成促黄体生成激素释放激素(LHRH)疫苗在大鼠体内的纵向显微光谱CT成像及药代动力学研究
Anticancer Res. 2007 Sep-Oct;27(5A):3251-8.
4
Stable and high-level production of recombinant Factor IX in human hepatic cell line.稳定且高水平地在人源性肝细胞系中生产重组凝血因子 IX。
Biotechnol Appl Biochem. 2011 Jul-Aug;58(4):243-9. doi: 10.1002/bab.32. Epub 2011 Aug 9.
5
Biodistribution and pharmacokinetics of 131I-labeled LEX 032, a recombinant hybrid of antichymotrypsin.131I标记的抗胰凝乳蛋白酶重组杂交体LEX 032的生物分布及药代动力学
Drug Metab Dispos. 1997 May;25(5):631-6.
6
Pilot production of recombinant human clotting factor IX from transgenic sow milk.从转基因母猪奶中中试生产重组人凝血因子 IX。
J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Jun 1;898:78-89. doi: 10.1016/j.jchromb.2012.04.022. Epub 2012 Apr 26.
7
Synthetic approaches and bio-distribution studies of [11C]methyl-phenidate.[11C]甲基苯丙胺的合成方法及生物分布研究。
J Pharm Pharm Sci. 2007;10(2):312s-320s.
8
Biodistribution of intravenously injected [131I]Lipiodol in rats.
Radiat Med. 1992 Sep-Oct;10(5):196-8.
9
Pharmacokinetics of lactosaminated recombinant human growth hormone in mice.乳糖胺化重组人生长激素在小鼠体内的药代动力学
Acta Pharmacol Sin. 2001 May;22(5):450-4.
10
ZT glue immobilizes iodinated oil in vivo.
Eur J Radiol. 2006 Nov;60(2):287-92. doi: 10.1016/j.ejrad.2006.06.001. Epub 2006 Jul 24.

引用本文的文献

1
FcRn Rescues Recombinant Factor VIII Fc Fusion Protein from a VWF Independent FVIII Clearance Pathway in Mouse Hepatocytes.FcRn从小鼠肝细胞中一条不依赖VWF的FVIII清除途径中拯救重组因子VIII Fc融合蛋白。
PLoS One. 2015 Apr 23;10(4):e0124930. doi: 10.1371/journal.pone.0124930. eCollection 2015.
2
Recombinant human factor IX produced from transgenic porcine milk.从转基因猪乳中生产的重组人凝血因子IX。
Biomed Res Int. 2014;2014:315375. doi: 10.1155/2014/315375. Epub 2014 May 18.
3
Molecular imaging, pharmacokinetics, and dosimetry of In-AMBA in human prostate tumor-bearing mice.
In-AMBA在荷人前列腺肿瘤小鼠中的分子成像、药代动力学及剂量学研究
J Biomed Biotechnol. 2011;2011:101497. doi: 10.1155/2011/101497. Epub 2011 May 24.